2017-18120. National Institute of Biomedical Imaging and Bioengineering Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering.

    The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering NACBIB Council Meeting, September, 2017.

    Date: September 12, 2017.

    Open: 9:00 a.m. to 12:40 p.m.

    Agenda: Report from the Institute Director, other Institute Staff and scientific presentation.

    Place: The William F. Bolger Center, Franklin Building, Classroom 4, 9600 Newbridge Drive, Potomac, MD 20854.

    Closed: 2:00 p.m. to 3:00 p.m.

    Agenda: To review and evaluate grant applications and/or proposals.

    Place: The William F. Bolger Center, Franklin Building, Classroom 4, 9600 Newbridge Drive, Potomac, MD 20854.

    Contact Person: David T. George, Ph.D., Acting Associate Director, Office of Research Administration, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Room 920, Bethesda, MD 20892.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    Information is also available on the Institute's/Center's home page: http://www.nibib1.nih.gov/​about/​NACBIB/​NACBIB.htm,, where an agenda and any additional information for the meeting will be posted when available.

    Start Signature

    Dated: August 22, 2017.

    Melanie J. Pantoja,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2017-18120 Filed 8-25-17; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
08/28/2017
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2017-18120
Dates:
September 12, 2017.
Pages:
40780-40780 (1 pages)
PDF File:
2017-18120.pdf